+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of extended-release methylphenidate (concerta) in treatment of cocaine dependence in a patient presenting with attention deficit hyperactivity disorder



Use of extended-release methylphenidate (concerta) in treatment of cocaine dependence in a patient presenting with attention deficit hyperactivity disorder



Journal of Neuropsychiatry and Clinical Neurosciences 26(3): E49-E50




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056797440

Download citation: RISBibTeXText

PMID: 25093790

DOI: 10.1176/appi.neuropsych.13080194


Related references

A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder. Cns Drugs 28(11): 1005-1033, 2015

Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate. Plos One 10(5): E0127237, 2016

Extended-release Methylphenidate Treatment and Outcomes in Comorbid Social Anxiety Disorder and Attention-deficit/Hyperactivity Disorder: 2 Case Reports. Journal of Psychiatric Practice 21(3): 225-231, 2016

Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists. Integrated Pharmacy Research and Practice 6: 163-171, 2018

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment. Neuropsychiatric Disease and Treatment 112: 1085-1101, 2016

General anesthesia in a juvenile with attention-deficit hyperactivity disorder accompanied by long-term use of methylphenidate (Concerta). Acta Anaesthesiologica Taiwanica 47(4): 208-211, 2010

Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion. Current Medical Research and Opinion 26(1): 129-137, 2010

Attention deficit hyperactivity disorder therapy update: extended-release methylphenidate. Revista de Neurologia 40(Suppl. 1): S49-S55, 2005

Clinical assessment of the effect of switch from immediate-release to extended-release methylphenidate in 181 patients with isolated attention deficit/hyperactivity disorder (AD/HD) or AD/HD associated with pervasive developmental disorder. No to Hattatsu 41(6): 436-441, 2009

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 27(6): 474-482, 2018

Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?. Child and Adolescent Psychiatry and Mental Health 3(1): 39, 2009

Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatric Drugs 5(8): 545-555, 2003

Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study. Journal of Child and Adolescent Psychopharmacology 18(3): 248-256, 2008

P.7.d.013 Guanfacine extended release for attention-deficit/hyperactivity disorder following inadequate response to prior methylphenidate. European Neuropsychopharmacology 24: S727-S728, 2014

Effect of extended-release methylphenidate on the ecological executive function for attention deficit hyperactivity disorder. Beijing Da Xue Xue Bao. Yi Xue Ban 39(3): 299-303, 2007